- Joined
- Dec 15, 2021
- Messages
- 4,278
- Points
- 113
while regular people are not allowed to.
Google Stromectol.Didn't say anything to substantiate such claims.
Regular people are allowed to take ivermectin
Regular people are allowed to take ivermectin
Just go to any GP and say you have head lice
No one stopping you
The queen has head lice?
U should do some homework to make your fake news a bit more credible
The truth slipped out I guess. Hard to put the genie back into the bottle now.
The queen has head lice?
surprised people still hawking ivermectin in 2022. so passé
time for the fake news pseudo science halfwits to roll out a new product in order to stay relevant
https://www.reuters.com/article/fac...-queen-covid-19-report-in-error-idUSL1N2UX0S1
Ahhhh ... so this is what made the conspiracy theorists go ape shit
https://sg.news.yahoo.com/tv-network-apologises-queen-ivermectin-covid-153616418.html
Anyway apologies issued. News network unlikely to be invited to Windsor this year for Christmas
https://www.euronews.com/next/2022/...ing-ivermectin-tv-blunder-fuels-false-rumoursWhat is there to apologise for? The truth is out and none of these subsequent retractions change the facts of the case. All it does is prove what lying scumbags the media has turned out to be. They'll report whatever their masters tell them to.
Stromectol was obviously mentioned as being part of the Queen's treatment. Why else would the MSM extract stock photos of the drug for insertion into the news report?
https://www.euronews.com/next/2022/...ing-ivermectin-tv-blunder-fuels-false-rumours
No evidence the royal physicians will be so stupid as to give her horse medicine
But entertaining to see conspiracy theorists howl with delight again . Whatever it takes to keep the circus running
niceStrange... no mention of "horses" in this article about a Nobel Prize winning drug.
Oct 27, 2015,12:00pm EDT
Nobel Prize-Winning Drug Ivermectin May Fight Malaria
Judy Stone
Senior Contributor
Healthcare
I am an Infectious Disease specialist and author of Resilience: One Family's Story of Hope and Triumph over Evil and of Conducting Clinical Research, the essential guide to the topic.
This article is more than 6 years old.
Resurrecting old drugs for unmet medical needs—known more formally as drug repurposing—was an important message in the Nobel Prize for Medicine earlier this month. It came up today, too, with the intriguing study showing that the antiparasitic drug, ivermectin, appears promising for disrupting malaria transmission.
This new finding was presented today at the American Society of Tropical Medicine and Hygiene (ASTMH) Annual Meeting by researchers from Colorado State University.
Ivermectin has been used for decades, given once per year as a part of Mass Drug Administration (MDA) programs, to reduce the disabling worm infections onchocerciasis, which causes river blindness, and filariasis, the cause of the hugely swollen legs (elephantiasis). Merck has generously donated the entire supply of drug; other companies have followed suit with different drugs for other neglected tropical diseases.
In sub-Saharan Africa, each year the deadly malaria parasite Plasmodium falciparum kills 584,000 people--most them children. For this initial study, researchers used the MDA approach to treat villages in the West African country of Burkina Faso during the rainy season, when the risk of malaria transmission is the highest. About 2,800 people were treated with ivermectin, given every three weeks and repeated six times. As they excluded pregnant or breast feeding women and small children, about 75% of the villagers were treated. The scientists found approximately a 16% reduction in childhood malaria episodes in the four villages, even though the young children were not directly treated.
How does this work? As Dr. Brian Foy, lead investigator, explained, only old female mosquitoes transmit malaria. It's also interesting that the malaria parasite takes two weeks to work its way into the salivary gland of the mosquito and during that time, it may bite up to five other people. If the villagers have received ivermectin, the mosquito gets multiple exposures to the drug. Foy continued, if you give ivermectin to the “Plasmodium in culture, nothing happens. It is not specifically toxic to Plasmodium. The effect is that when mosquitoes bite you, if you’ve taken the drug, it will die.” Transmission from person to person is thus reduced, leading to the drop in deaths. While Foy notes that "there isn’t anything a mosquito hasn’t developed resistance to," he's optimistic that this pulsed dosing of a mosquitocidal drug will be an important tool.
Not just Africa will benefit from Ivermectin. In a related study, Kevin Kobylinski of the U.S. Walter Reed Army Institute of Research (WRAIR) showed that ivermectin can block development of Plasmodium vivax parasites in mosquitoes that are common in Southeast Asia as well as killing the host Anopheles dirus mosquitoes. Kobylinski notes, “It can be hard to convince someone to take malaria medications if they don't have an active malaria infection," but hopes that people will be more accepting of ivermectin, even if they don’t yet have malaria, because it will effectively treat scabies.
And dengue plus cikikuniya too.Prize-Winning Drug Ivermectin May Fight Malaria